Treyer Valerie, Jobin Mathieu, Burger Cyrill, Teneggi Vincenzo, Buck Alfred
PET Center, Division of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):572-80. doi: 10.1007/s00259-002-1105-x. Epub 2003 Jan 28.
The quantitative determination of regional cerebral blood flow (rCBF) is important in certain clinical and research applications. The disadvantage of most quantitative methods using H(2)(15)O positron emission tomography (PET) is the need for arterial blood sampling. In this study a new non-invasive method for rCBF quantification was evaluated. The method is based on the washout rate of H(2)(15)O following intravenous injection. All results were obtained with Alpert's method, which yields maps of the washin parameter K(1) (rCBF(K1)) and the washout parameter k(2) (rCBF(k2)). Maps of rCBF(K1) were computed with measured arterial input curves. Maps of rCBF(k2*) were calculated with a standard input curve which was the mean of eight individual input curves. The mean of grey matter rCBF(k2*) (CBF(k2*)) was then compared with the mean of rCBF(K1) (CBF(K1)) in ten healthy volunteer smokers who underwent two PET sessions on day 1 and day 3. Each session consisted of three serial H(2)(15)O scans. Reproducibility was analysed using the rCBF difference scan 3-scan 2 in each session. The perfusion reserve (PR = rCBF(acetazolamide)-rCBF(baseline)) following acetazolamide challenge was calculated with rCBF(k2*) (PR(k2*)) and rCBF(K1) (PR(K1)) in ten patients with cerebrovascular disease. The difference CBF(k2*)-CBF(K1) was 5.90+/-8.12 ml/min/100 ml (mean+/-SD, n=55). The SD of the scan 3-scan 1 difference was 6.1% for rCBF(k2*) and rCBF(K1), demonstrating a high reproducibility. Perfusion reserve values determined with rCBF(K1) and rCBF(k2*) were in high agreement (difference PR(k2*)-PR(K1)=-6.5+/-10.4%, PR expressed in percentage increase from baseline). In conclusion, a new non-invasive method for the quantitative determination of rCBF is presented. The method is in good agreement with Alpert's original method and the reproducibility is high. It does not require arterial blood sampling, yields quantitative voxel-by-voxel maps of rCBF, and is computationally efficient and easy to implement.
局部脑血流量(rCBF)的定量测定在某些临床和研究应用中很重要。大多数使用H(2)(15)O正电子发射断层扫描(PET)的定量方法的缺点是需要采集动脉血样。在本研究中,评估了一种新的rCBF定量无创方法。该方法基于静脉注射后H(2)(15)O的清除率。所有结果均采用阿尔珀特方法获得,该方法可生成灌注参数K(1)(rCBF(K1))和清除参数k(2)(rCBF(k2))的图谱。rCBF(K1)图谱通过测量的动脉输入曲线计算得出。rCBF(k2*)图谱使用标准输入曲线计算,该标准输入曲线是八条个体输入曲线的平均值。然后,在10名健康志愿者吸烟者中比较灰质rCBF(k2*)(CBF(k2*))的平均值与rCBF(K1)(CBF(K1))的平均值,这些志愿者在第1天和第3天接受了两次PET检查。每次检查包括三次连续的H(2)(15)O扫描。使用每次检查中rCBF差异扫描3 - 扫描2分析可重复性。在10名脑血管疾病患者中,用rCBF(k2*)(PR(k2*))和rCBF(K1)(PR(K1))计算乙酰唑胺激发后的灌注储备(PR = rCBF(乙酰唑胺)-rCBF(基线))。CBF(k2*)-CBF(K1)的差异为5.90±8.12 ml/min/100 ml(平均值±标准差,n = 55)。rCBF(k2*)和rCBF(K1)的扫描3 - 扫描1差异的标准差为6.1%,表明具有高可重复性。用rCBF(K1)和rCBF(k2*)测定的灌注储备值高度一致(差异PR(k2*)-PR(K1)= -6.5±10.4%,PR以相对于基线的百分比增加表示)。总之,提出了一种新的rCBF定量无创方法。该方法与阿尔珀特的原始方法高度一致,且可重复性高。它不需要采集动脉血样,可生成rCBF的逐体素定量图谱,并且计算效率高且易于实施。